DA Davidson Says Cellebrite's Market Is Bigger Than You Think
DA Davidson is bullish on CLBT, arguing the company's total addressable market is large, expanding, and likely undervalued by the Street.
If you've been sleeping on Cellebrite (CLBT), DA Davidson thinks you're making a mistake. The firm is out with a fresh take on the digital intelligence company, making the case that its total addressable market isn't just big — it's bigger than most investors are giving it credit for.
DA Davidson's core argument is straightforward: the TAM for Cellebrite's investigative analytics and digital forensics tools is large, actively growing, and — crucially — understated in conventional market estimates. That last point is the kicker. When the Street underestimates a TAM, it tends to undervalue the stock. That's the tradeable insight here.
Read more Prediction Markets Raise Insider Trading Red Flags for Wall Street →
Cellebrite sits at the intersection of law enforcement technology and enterprise digital investigations, a niche that keeps expanding as data volumes explode and regulators worldwide demand more sophisticated evidence-gathering tools. The company isn't chasing a static pie — it's operating in a space where the pie keeps getting larger, whether driven by cybercrime, corporate investigations, or government contracts.
For retail traders, the DA Davidson call is worth watching. Analyst upgrades or bullish TAM reassessments can act as near-term catalysts, especially for mid-cap names that don't get the same institutional coverage as large-cap tech. If the broader market agrees with Davidson's read on the addressable opportunity, the re-rating could have legs.
Bottom line: CLBT is a name where the growth narrative may be structurally more compelling than current valuations reflect. Keep it on your radar. Continue reading at Yahoo Finance.
